HIT Consultant
MARCH 18, 2024
These microservices, with 25 newly launched offerings, are poised to expedite healthcare workflows in drug discovery, medical imaging, and genomics analysis. Cadence, a computational software leader, integrates NVIDIA BioNeMo microservices into its Orion molecular design platform, enhancing drug discovery capabilities.
HIT Consultant
APRIL 8, 2024
About Model N Model N is a leader in revenue optimization and compliance solutions, empowering companies in the pharmaceutical, medical technology, and high-tech sectors. Upon completion, Model N will become a privately held company and its shares will be delisted from any public stock exchange.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
AUGUST 30, 2023
AI also has the potential to identify, and even design, up to 50 new therapeutic drugs in the next decade, representing a $ 50 billion opportunity for the global pharmaceutical industry, with a 20-40% reduction in pre-clinical costs. IvorIvor has been in a candidate search for more than 30 years.
Healthcare Leadership Council
NOVEMBER 17, 2022
The Bayh-Dole Act, enacted in 1980, decentralized technology from Washington bureaucracy and allowed the people creating biopharmaceutical and medical technology innovations to own and manage them, integrating incentives into the patent-and-licensing process and jumpstarting a renaissance in healthcare innovation.
HIT Consultant
SEPTEMBER 1, 2021
With this in mind, it is critical that both payers and providers in VBC arrangements consider how their data flows through the entire system so that key partners, such as life sciences and pharmaceutical companies – have real-world insights (RWI) about the impact their medication is having on outcomes.
Health Populi
APRIL 6, 2022
This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.
HIT Consultant
AUGUST 18, 2021
Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA. The acceleration of digital advancements and collaborative practices amongst the pharmaceutical industry during COVID-19 have enabled a historic rollout of vaccines. The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools.
Expert insights. Personalized for you.
96 
Let's personalize your content